Page last updated: 2024-11-05

nikethamide and Obesity

nikethamide has been researched along with Obesity in 3 studies

Nikethamide: A central nervous system stimulant. It was formerly used in the treatment of barbiturate overdose but is now considered to be of no value for such purposes and may be dangerous. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1229)

Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
LIUBSKAIA, II1
Mallach, HJ1
Pedal, I1
Lächler, H1
Ladi, MP1
Borsò, MT1

Other Studies

3 other studies available for nikethamide and Obesity

ArticleYear
[Use of phenatin in treatment of obesity; preliminary report].
    Sovetskaia meditsina, 1958, Volume: 22, Issue:10

    Topics: Niacin; Nicotinic Acids; Nikethamide; Obesity

1958
[The anti-obesity agent X112 in the drug scene].
    Die Medizinische Welt, 1980, Feb-08, Volume: 31, Issue:6

    Topics: Adolescent; Adult; Central Nervous System Stimulants; Drug Prescriptions; Ephedrine; Female; Humans;

1980
[Comparative evaluation of the respiratory effects of some analeptics].
    Minerva medica, 1966, Feb-07, Volume: 57, Issue:11

    Topics: Adult; Aged; Aminobutyrates; Bronchitis; Central Nervous System Stimulants; Female; Flavonoids; Huma

1966